Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Cohen Cheryl
Over the trailing 90 days, Cohen Cheryl (Director at ImmunityBio, Inc.) traded $1.4M of stock (net selling $1.1M) across 2 companies, per 5 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 5 transactions · CIK 1529371
- Net activity
- −$1.1M ($167K bought · $1.2M sold)
By Company (Trailing 90 Days)
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-02 | IBRX | Buy | 56.0K | $167K | Exercise or conversion of derivative security |
| 2026-07-02 | IBRX | Sell | 131.2K | $1.2M | Open market or private sale |
| 2026-07-02 | IBRX | Sell | 56.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-25 | CLDX | Buy | 26.0K | $0 | Grant, award or other acquisition |
| 2026-06-09 | IBRX | Buy | 65.6K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Cohen's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.